| Name | mitogen-activated protein kinase kinase kinase 20 |
| Description | This gene is a member of the MAPKKK family of signal transduction molecules and encodes a protein with an N-terminal kinase catalytic domain, followed by a leucine zipper motif and a sterile-alpha motif (SAM). This magnesium-binding protein forms homodimers and is located in the cytoplasm. The protein mediates gamma radiation signaling leading to cell cycle arrest and activity of this protein plays a role in cell cycle checkpoint regulation in cells. The protein also has pro-apoptotic activity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n MAP3K20—also referred to as ZAK, MLK7, or MLTK—is a stress‐activated mitogen‑activated protein kinase kinase kinase (MAPKKK) that plays a multifaceted role in integrating and transducing extracellular and intracellular signals through the ERK, JNK, and p38 pathways. In hepatocellular carcinoma, for example, high expression of a nearby long non‑coding RNA (URHC) suppresses ZAK expression, leading to inactivation of the ERK/MAPK cascade, enhanced cell proliferation, and reduced apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In contrast, in gastric cancer a particular isoform of ZAK (TV1) is preferentially up‑regulated, where its overexpression activates several oncogenic transcription factors and promotes cell proliferation—findings that support an oncogenic function of MAP3K20 in certain tumor contexts."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its role in cancer, MAP3K20 is instrumental in mediating cellular stress responses. In models of ricin intoxication, cells lacking ZAK fail to activate p38 and JNK1/2 and show decreased induction of stress response genes, while in vivo deletion of ZAK affords protection from toxin‐induced tissue damage."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Structural and substrate specificity analyses of ZAK reveal unique conformational features that not only contribute to its catalytic function but also highlight opportunities for rational inhibitor design—important given that off‑target inhibition of ZAK has been associated with adverse effects during anticancer therapy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Several studies further underscore the importance of MAP3K20 in diverse biological processes. Functional investigations demonstrate that the kinase activity and downstream signaling of MAP3K20 (in its MLK7/MLTK forms) are critical for stress‐induced actin cytoskeleton reorganization and morphological change via p38 and JNK pathway activation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " In cardiac and skeletal muscle as well as in certain transformed cells, over‑expression of MAP3K20/MLK7 drives neoplastic transformation and contributes to cardiac hypertrophy, thereby linking its signaling to both tumorigenesis and pathological tissue remodeling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Moreover, during embryogenesis MAP3K20 regulates chondrogenesis by promoting the Sox9‑dependent induction of Sox6 via downstream p38 and JNK signaling"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ", and activation of MAP3K20 is further modulated by its phosphorylation via upstream kinases such as PKNα, which enhances its catalytic and scaffold activities for specific MAPK cascades."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, MAP3K20 is a versatile signaling hub whose context‑dependent regulation influences critical cellular outcomes—including cell proliferation, apoptosis, differentiation, and stress response. Its diverse roles in cancer progression, tissue remodeling, and normal developmental processes make it a promising target for therapeutic intervention across a range of pathologies.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Wei-Hua Xu, Jian-Bin Zhang, Zheng Dang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.8232"}], "href": "https://doi.org/10.7150/ijbs.8232"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25013376"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25013376"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jinfeng Liu, Mark McCleland, Eric W Stawiski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms4830"}], "href": "https://doi.org/10.1038/ncomms4830"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24807215"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24807215"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Dakshina M Jandhyala, John Wong, Nicholas J Mantis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Novel Zak Knockout Mouse with a Defective Ribotoxic Stress Response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxins (Basel) (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/toxins8090259"}], "href": "https://doi.org/10.3390/toxins8090259"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27598200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27598200"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Sebastian Mathea, Kamal R Abdul Azeez, Eidarus Salah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "ACS Chem Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acschembio.6b00043"}], "href": "https://doi.org/10.1021/acschembio.6b00043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26999302"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26999302"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "I Gotoh, M Adachi, E Nishida "}, {"type": "b", "children": [{"type": "t", "text": "Identification and characterization of a novel MAP kinase kinase kinase, MLTK."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M008595200"}], "href": "https://doi.org/10.1074/jbc.M008595200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11042189"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11042189"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xiaohong Yu, Laura J Bloem "}, {"type": "b", "children": [{"type": "t", "text": "Effect of C-terminal truncations on MLK7 catalytic activity and JNK activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2003.09.075"}], "href": "https://doi.org/10.1016/j.bbrc.2003.09.075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14521931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14521931"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Toshiyasu Suzuki, Morioh Kusakabe, Kei Nakayama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The protein kinase MLTK regulates chondrogenesis by inducing the transcription factor Sox6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Development (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/dev.078675"}], "href": "https://doi.org/10.1242/dev.078675"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22764049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22764049"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mikiko Takahashi, Yusuke Gotoh, Takayuki Isagawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jb/mvg022"}], "href": "https://doi.org/10.1093/jb/mvg022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12761180"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12761180"}]}]}]}
|
| NCBI Gene ID | 51776 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MAP3K20 has 4,734 functional associations with biological entities spanning 6 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 47 datasets.
Click the + buttons to view associations for MAP3K20 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MAP3K20 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MAP3K20 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MAP3K20 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MAP3K20 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MAP3K20 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with MAP3K20 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of MAP3K20 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing MAP3K20 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MAP3K20 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of MAP3K20 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MAP3K20 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for MAP3K20 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MAP3K20 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MAP3K20 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MAP3K20 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MAP3K20 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MAP3K20 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MAP3K20 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MAP3K20 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MAP3K20 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MAP3K20 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MAP3K20 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MAP3K20 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with MAP3K20 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with MAP3K20 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with MAP3K20 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MAP3K20 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MAP3K20 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving MAP3K20 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MAP3K20 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MAP3K20 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MAP3K20 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MAP3K20 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MAP3K20 protein from the Wikipathways PFOCR 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MAP3K20 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MAP3K20 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MAP3K20 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of MAP3K20 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MAP3K20 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MAP3K20 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with MAP3K20 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MAP3K20 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MAP3K20 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MAP3K20 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MAP3K20 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MAP3K20 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MAP3K20 protein from the WikiPathways Pathways 2024 dataset. | |